title: The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article].
authors.forename: J H
authors.initials: JH
authors.lastname: Noseworthy
authors.forename: G C
authors.initials: GC
authors.lastname: Ebers
authors.forename: M K
authors.initials: MK
authors.lastname: Vandervoort
authors.forename: R E
authors.initials: RE
authors.lastname: Farquhar
authors.forename: E
authors.initials: E
authors.lastname: Yetisir
authors.forename: R
authors.initials: R
authors.lastname: Roberts
mesh_terms: D003520:Cyclophosphamide / Q000266:history* / Q000627:therapeutic use; D005260:Female; D049673:History, 20th Century; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000266:history* / Q000628:therapy; D009460:Neurologic Examination / Q000266:history; D010951:Plasma Exchange / Q000266:history*; D011241:Prednisone / Q000266:history* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000266:history; D016037:Single-Blind Method
chemical_list: D003520:Cyclophosphamide; D011241:Prednisone